Inc500

News & Events - Inc. 500 Press Release

TeleChem joins Inc 500 elite.

Sunnyvale, CA, Nov 5, 2002 – On October 15th, Inc. Magazine announced that TeleChem International, Inc. was chosen as one of the top 500 fastest growing privately held companies in America. The list was generated by Inc. magazine using highly stringent business management and accounting criteria including revenues, growth, and profitability over a five-year period. Of the 500 companies chosen, TeleChem International, Inc. was one of only two biotechnology companies on the list, and the only private company in the United States that showed profits in every evaluation period. TeleChem International, Inc. continues to excel through innovation and by providing superior technology and services in the biotechnology, industrial chemicals, and medical diagnostics markets.

"This is the first Inc. 500 ranking to reflect the full impact of the recession," said editor John Koten. "Yet these entrepreneurs are managing to confound the naysayers and move ahead despite the obstacles. They are showing that smart strategies can succeed even in the toughest times."

The average 5-year growth rate of this year's Inc. 500 companies is 1,521%. Inc. verifies information for every company on the list using tax forms and financial statements from certified public accountants. Former Inc. 500 companies that have gone on to be household names include Microsoft, Timberland, and Domino's Pizza.

Rene’ Schena, President of TeleChem International, Inc. said, "We are pleased to be recognized in this manner. Our team has worked very hard to stay profitable while providing our customers with top quality products and services. The future is very bright and we're leading the way in our industry." To learn more about TeleChem International, Inc. and the Inc 500 click HERE.

About TeleChem International, Inc.
TeleChem International is a privately owned high-tech company located in the heart of California’s Silicon Valley. Our products and services are provided by three corporate divisions: ArrayIt® Life Sciences Division, Chemicals Division, and a Diagnostics Division. The ArrayIt® Life Sciences Division offers a complete microarray technology platform that empowers >10,000 laboratories to use microarrays for human genome exploration, basic research, drug discovery, and myriad life sciences applications. Nearly every major research institution uses our patented microarray manufacturing technology (U.S. 6,101,946) and supporting products and services. The Chemicals Division provides import and export services and government contract manufacturing in the area of industrial chemicals for plastics, fire control, water treatment, agriculture, industrial and institutional compounding, and green energy. The Diagnostics Division holds key patents in the United States (6,913,879), Singapore (94899), New Zealand (523560), and other countries for its revolutionary “multi-patient” genotyping technology, which allows as many as 100,000 patients to be tested on a single microarray. Arrayit Diagnostics enables genotyping and disease diagnostics by providing testing kits, services, and technology transfer opportunities for disease screening and testing organizations.

Media Contact
Paul Haje
Director of Public Relations
408-744-1331
Email paul@ArrayIt.com